The coronavirus pandemic has caused massive shocks to the global economy and dampened previously projected growth scenarios worldwide. According to a recent study, clothing and footwear retail was predicted to suffer a **** percent decline annually in 2020. However, with the diminishing of the impact of the pandemic, in 2021 the sector is forecast to grow by **** percent. In total terms, the retail industry is expected to grow by *** percent, as opposed to the *** percent decline in 2020. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Fact and Figures page.

According to a recent study on the impact of the coronavirus (COVID-19), the food and grocery retail sector in the United Kingdom (UK) is predicted to see a *** percent growth. In contrast, clothing and footwear retail is forecast to suffer significant losses, with a ** percent decrease in spending going into this sector.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Fact and Figures page.

Questions asked of participants with corresponding forecast medians, median absolute deviation (MAD), median absolute error (MAE) and median relative error (MRE).

First reported in Wuhan, China, in December 2019, now more than 846,200 confirmed cases of COVID-19 are spread across 187 countries worldwide. The US and several countries in Europe such as Italy, Spain, and Belgium have continued to see a decrease in daily cases. Russia, Brazil, and Latin American countries are seeing increasing trends. India has also seen an increase in the number of new cases reported despite strict distancing measures taken early on.
Special populations analysis covered in the report include the following:
COVID-19 in children may result in systemic multisystem syndrome with severe outcomes.
Childhood routine vaccination rates drop during pandemic.
COVID-19’s impact in pregnant women unclear, though most cases are asymptomatic.
The COVID-19 pandemic could cause an increase in the prevalence of post-traumatic stress disorder (PTSD).
Complications of opioid addiction will be challenging for the management of disease during the COVID-19 pandemic. Read More

The economy of the United Kingdom is expected to fall by ** percent in the second quarter of 2020, following the Coronavirus outbreak and closure of several businesses. According to the forecast the economy will bounce back in the third quarter of 2020, based on a scenario where the lockdown lasts for three months, with social distancing gradually phased out over a subsequent three-month period.

This publication is an update and extension to the Excel model containing the patient-based sales forecast for COVID-19 vaccines, which was previously covered in Coronavirus Disease 2019 (COVID 19) Vaccines: Opportunity Assessment and Forecast to 2026, published in June 2021. Read More

Current Epidemiology Situation and Forecast
To date, the greatest numbers of cases and deaths have occurred in the US, India, and Brazil
The global case fatality rate (%) has continued to decline
Increasing uncertainty of infection rates renders forecasting difficult in the worst-hit countries Read More

Snapshot img

Europe Coronavirus Test Kits Market Size 2024-2028

The coronavirus test kits market in Europe size is forecast to decrease by USD 1.89 billion at a CAGR of -72.5% between 2023 and 2028.

The European coronavirus test kits market is experiencing significant growth due to the increasing demand for rapid diagnostic solutions. The emergence of SARS-CoV-2 variants, such as the Delta variant, has highlighted the importance of accurate and timely testing. Oropharyngeal swabs, nasal swabs, and sputum samples are commonly used for diagnosing COVID-19 infections. Point-of-Care (PoC) kits have gained popularity due to their convenience and quick results. However, the accuracy of diagnostic tests remains a challenge, with the Indian Council of Medical Research (ICMR) and the Health Ministry reporting false positives and negatives. The market is expected to continue its expansion as the world navigates the ongoing pandemic.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The European coronavirus test kits market is witnessing significant growth due to the ongoing pandemic caused by SARS-CoV-2. The demand for test kits is driven by the need for early detection and rapid screening of infected individuals to prevent the spread of the virus within communities. According to the medical device database from GlobalData, RT-PCR tests remain the gold standard for diagnosing SARS-CoV-2 infection. These tests detect viral genetic material from human nasal samples, providing accurate results. However, the time-consuming nature of these tests and the requirement for specialized equipment have led to the emergence of alternative solutions, such as SARS-CoV-2 antigen tests.
Moreover, rapid antigen tests, also known as point-of-care (PoC) kits, offer user-friendly solutions for healthcare systems. These tests provide results within minutes, making them ideal for mass screening in various settings, including schools, workplaces, and airports. The Delta variant and the emerging Omicron variant of SARS-CoV-2 have added to the urgency for effective testing solutions. The European Union has been proactive in addressing this need, with initiatives such as the European Health Union and the EU Digital COVID Certificate system. The European coronavirus test kits market is expected to continue its growth trajectory, driven by the ongoing pandemic and the need for regular testing to ensure public health and safety

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Government
  Non government


Type

  Rapid test kit
  RT-PCR
  Others


Geography

  Europe

    Germany
    UK
    France

By End-user Insights

The government segment is estimated to witness significant growth during the forecast period.

In Europe, various diagnostic techniques are utilized to identify COVID-19 cases, with WHO recommending that countries with limited testing capacity or inexperienced national laboratories send their initial positive and negative samples to five referral laboratories in Europe for confirmatory testing. These laboratories include the German coronavirus diagnostic working group at Charite and Robert Koch Institute in Berlin, Erasmus Medical Center in Rotterdam, the Institute Pasteur in Paris, and the Respiratory Virus Unit at Public Health England. Additionally, several other laboratories in Belgium, Luxembourg, the Netherlands, and Spain offer diagnostic testing support. In the UK, Public Health England (PHE) regional laboratories provide testing facilities alongside WHO referral laboratories. As the world awaits vaccinations and booster doses, public awareness remains crucial. During the flu season, mask mandates and social distancing measures continue to be essential preventative measures.

Get a glance at the market report of share of various segments Request Free Sample

Market Dynamics

Our Europe Coronavirus Test Kits Market researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of the European coronavirus Test Kits Market?

Rising adoption of rapid coronavirus test kits is the key driver of the market.

In Europe, the coronavirus pandemic has put immense pressure on healthcare systems, particularly in terms of diagnostic capabilities. To mitigate this challenge, European governments have prioritized expanding their testing capacity through various means. In 2022, there was a significant push to distribute coronavirus test kits across

BackgroundPredicting the future UK COVID-19 epidemic provides a baseline of a vaccine-only mitigation policy from which to judge the effects of additional public health interventions. A previous 12-month prediction of the size of the epidemic to October 2022 underestimated its sequelae by a fifth. This analysis seeks to explain the reasons for the underestimation before offering new long-term predictions.MethodsA Dynamic Causal Model was used to identify changes in COVID-19 transmissibility and the public's behavioral response in the 12-months to October 2022. The model was then used to predict the future trends in infections, long-COVID, hospital admissions and deaths over 12-months to October 2023.FindingsThe model estimated that the secondary attack rate increased from 0.4 to 0.5, the latent period shortened from 2.7 to 2.6 and the incubation period shortened from 2.0 to 1.95 days between October 2021 and October 2022. During this time the model also estimated that antibody immunity waned from 177 to 160 days and T-cell immunity from 205 to 180 days. This increase in transmissibility was associated with a reduction in pathogenicity with the proportion of infections developing acute respiratory distress syndrome falling for 6–2% in the same twelve-month period. Despite the wave of infections, the public response was to increase the tendency to expose themselves to a high-risk environment (e.g., leaving home) each day from 33–58% in the same period.The predictions for October 2023 indicate a wave of infections three times larger this coming year than last year with significant health and economic consequences such as 120,000 additional COVID-19 related deaths, 800,000 additional hospital admissions and 3.5 million people suffering acute-post-COVID-19 syndrome lasting more than 12 weeks.InterpretationThe increase in transmissibility together with the public's response provide plausible explanations for why the model underestimated the 12-month predictions to October 2022. The 2023 projection could well-underestimate the predicted substantial next wave of COVID-19 infection. Vaccination alone will not control the epidemic. The UK COVID-19 epidemic is not over. The results call for investment in precautionary public health interventions.

This study is a longitudinal cohort study using the Coronavirus Health Impact Survey (CRISIS) collected at 3 time points: an initial assessment in April 2020 (“April”), a reassessment 3 weeks later (“May”), and a 7-month follow-up in November 2020 (“November”). Online surveys were collected in the United States and the United Kingdom by a survey recruitment service with a final sample of 859 adults and 780 children (collected via parent report).

Differential expression was determined in Calu-3 cells between mock infected and infection with either Human coronavirus EMC and SARS coronavirus at different times post infection. Calu-3 2B4 cells were infected with Human Coronavirus EMC 2012 (HCoV-EMC) or mock infected. Samples were collected 0, 3, 7, 12, 18 and 24 hpi. There are 3 mock and 3 infected replicates for each time point, except for 12 hpi for which there are only 2 infected replicates (one replicate did not pass RNA quality check). There were no mock sampes at 18 hpi, and therefore infected samples at 18 hpi were compared with mocks at 24 hpi. For direct comparison with SARS-CoV infected cells, raw data from HCoV-EMC experiments were quantile normalized together with the SARS-CoV dataset (GEO Series accession number GSE33267).

General Hospital Supplies (Hospital Supplies) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Hospital Supplies therapeutic area. Read More

Text corpus and Big Five leadership traits as demonstrated in Brown, Horvath, and Stevens (2021) "Moonshots or a Cautious Take-Off? How the Big Five Leadership Traits Predict Covid Policy Response" (working paper).

According to a 2021 forecast, total tourism expenditure in England, including the spending of international and domestic overnight travelers, is expected to decrease by over ** billion British pounds in the second half of 2021 over the same period of 2019. As predicted, London would record the highest drop, with total tourism expenditure declining from **** million British pounds to around **** billion British pounds over the period considered.

Political conservatives’ opposition to COVID-19 restrictions is puzzling given the well-documented links between conservatism and conformity, threat sensitivity, and pathogen aversion. We propose a resolution based on the Dual Foundations Theory of ideology, which holds that ideology comprises two dimensions, one reflecting trade-offs between threat-driven conformity and individualism, and another reflecting trade-offs between empathy-driven co-operation and competition. We test predictions derived from this theory in a UK sample using individuals’ responses to COVID-19, and widely-used measures of the two dimensions – ‘right-wing authoritarianism’ (RWA) and ‘social dominance orientation’ (SDO), respectively. Consistent with our predictions, we show that RWA but not SDO increased following the pandemic, and that high-RWA conservatives do, in fact, display more concerned, conformist, pro-lockdown attitudes, while high-SDO conservatives display less empathic, cooperative attitudes and are anti-lockdowns. This helps explain paradoxical prior results and highlights how a focus on unidimensional ideology can mask divergent motives across the ideological landscape.

This report contains a summary of the analyst consensus forecasts available in the GlobalData Pharma Intelligence Center Drug Sales and Analyst Consensus Database for the Indication COVID-19. Currently there are 23 drugs indicated for COVID-19 which have analyst consensus forecasts available. Read More

Capnographs (Anesthesia and Respiratory Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area. Read More

Here we recorded serum proteome profiles of 33 COVID-19 patients admitted to the ICU. We received, for most patients, blood samples just after admission and at two more later timepoints. We focused on serum proteins different in abundance between the group of survivors and non-survivors and observed that a rather small panel of about a dozen proteins were significantly different in abundance between these two groups. The four structurally and functionally related type-3 cystatins AHSG, FETUB, HRG and KNG1 were all more abundant in the survivors. The family of inter-α-trypsin inhibitors, ITIH1, ITIH2, ITIH3 and ITIH4, were all found to be differentially abundant in between survivors and non-survivors, whereby ITIH1 and ITIH2 were more abundant in the survivor group and ITIH3 and ITIH4 more abundant in the non-survivors. ITIH1/ITIH2 and ITIH3/ITIH4 also did show opposite trends in protein abundance during disease progression. This panel of eight proteins, complemented with a few more, may represent a panel for mortality risk assessment and eventually even for treatment, by administration of exogenous proteins possibly aiding survival. Such administration is not unprecedented, as administration of exogenous inter-α-trypsin inhibitors is already used in the treatment of patients with severe sepsis and Kawasaki disease. The mortality risk panel defined here is in excellent agreement with findings in two recent COVID-19 serum proteomics studies on independent cohorts, supporting our findings. This panel may not be unique for COVID-19, as some of the proteins here annotated as mortality risk factors have previously been annotated as mortality markers in aging and in other diseases caused by different pathogens, including bacteria.

Coronary Stents (Cardiovascular) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area. Read More